Review Article - International Journal of Respiratory Medicine (2021) Volume 6, Issue 1
The possible therapeutic options against COVID-19.
Aim: COVID-19 by SARS-CoV-2 is among the severe respiratory disease to be witnessed to date. SARS-Cov-2 brought about which is caused therapeutic difficulties all over the globe. The aim of this review is to evaluate the best possible therapeutic options to tackle the Novel Coronavirus related disease.
Method: Relevant published studies with keywords such as COVID-19 therapy, Sars-Cov-2 treatment and Novel Coronavirus antiviral therapy were extracted from different scientific journals and studied carefully.
Results: Some antiviral drugs, traditional Chinese medicine, immuno modulator drugs and quinoline have shown therapeutic abilities against Sars-Cov-2. However, tocilizumab and remdesvir have shown superiority over other groups of drugs.
Conclusion: Tocilizumab, an immuno modulator drug and viral protease inhibitor remdesivir have shown high efficacy against new coronavirus which raise the necessity for more research about these drugs.Author(s): Ahmad F Kombo, Zhi-Guang Ren, Da-yong Wang, Dong-dong Wu, Xi Ying Ji